17 January 2017
News and Views
Links and Services
A study published ahead of print the Alimentary Pharmacology & Therapeutics investigates adverse events of telaprevir-based therapy in patients with and without advanced fibrosis or cirrhosis.
Data about adverse events are needed to optimise telaprevir-based therapy in a broad spectrum of
Email this page to a colleague
GastroHep.com is a Blackwell Publishing registered trademark
© 2017 Wiley-Blackwell and GastroHep.com and contributors